Elianne D. B.
- Country
- The Netherlands
- Department
- Medical Oncology
Research Overview
- A Phase 3 Study of MK-2870 Versus Investigator’s Choice of Non-platinum Chemotherapy in Participants with Pretreated Locally Advanced or Metastatic Urothelial Carcinoma
- Phase II Randomized Trial of Preoperative Nivolumab With or Without Relatlimab in Stage II-IIIa Muscle-Invasive Urothelial Bladder Cancer
- Dose Optimization of Nivolumab in Patients with Melanoma or Renal Cell Carcinoma Exhibiting Complete, Partial, or Stable Response
Data & Insights
Has run more than one trial at 26 of 135 partner sites.
Specializations
Oncology Research
This investigator specializes in treating various forms of cancer, with particular emphasis on melanoma and renal cell carcinoma. Their research extends to innovative treatment approaches using immunotherapy agents.
- Advanced Melanoma Management
- Renal Cell Carcinoma Treatment
- Immunotherapy Optimization
The investigator focuses on developing optimal dosing strategies for cancer immunotherapy treatments.
Urological Oncology
Specialized research in urothelial cancer treatment, particularly focusing on muscle-invasive bladder cancer. The investigator explores neo-adjuvant therapeutic approaches for early-stage disease.
- Bladder Cancer Treatment
- Neo-adjuvant Therapy
- Stage II-IIIa Disease Management
Their work encompasses innovative combination therapy approaches for resectable urothelial cancer.
Immunotherapy Innovation
The investigator studies advanced immunotherapy combinations and treatment optimization strategies. Their research includes evaluating novel therapeutic combinations and dosing schedules.
- Treatment Response Assessment
- Combination Therapy Development
- Dosing Strategy Optimization
Focus areas include steady-state drug level assessment and therapeutic response monitoring.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.